Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Elevai Labs Inc’s current trading price is -99.67% away from its 52-week high, while its distance from the 52-week low is 47.68%. The stock’s price range during this period has varied between $1.74 and $778.00. The company, active in the Healthcare sector, saw a trading volume of around 2.27 million for the day, considerably higher average daily volume of 0.79 million observed over the last three months.
Elevai Labs Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $778.00 on 01/16/24, with the lowest value being $1.74 on 12/02/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Elevai Labs Inc (ELAB) has experienced a quarterly decline of -95.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.89M and boasts a workforce of 18 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 36.08, with a change in price of -97.41. Similarly, Elevai Labs Inc recorded 538,516 in trading volume during the last 100 days, posting a change of -97.43%.
How ELAB’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ELAB stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
ELAB Stock Stochastic Average
As of today, the raw stochastic average of Elevai Labs Inc over the past 50 days is 2.37%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 11.72%. Additionally, the Stochastic %K and %D values for the company were 7.01% and 5.43%, respectively, over the past 20 days.
ELAB Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -99.30% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -97.93%. Over the past 30 days, the price of ELAB has leaped by -32.01%. And in the last five days, it has surged by 29.15%.
